AbbVie Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021
Market Cap	364,649	403,970	409,212	327,805	370,073	313,686	348,968	302,895	321,538	273,668	263,163	237,771	281,124	285,917	237,338	270,791	286,428	239,433	190,693	199,038
Market Cap Growth	-1.47%	28.78%	17.26%	8.22%	15.09%	14.62%	32.61%	27.39%	14.38%	-4.28%	10.88%	-12.19%	-1.85%	19.41%	24.46%	36.05%	49.90%	26.59%	23.33%	14.91%
Enterprise Value	426,767	460,195	470,345	389,898	431,059	368,510	400,231	347,829	367,317	313,083	305,541	284,849	333,724	335,857	285,901	321,884	342,421	293,834	252,536	264,717
Last Close Price	206.23	228.49	231.54	185.62	209.52	177.70	197.48	171.52	182.10	154.97	149.06	134.73	159.37	161.61	134.21	153.16	162.11	135.40	107.87	112.64
PE Ratio	88.28	96.82	175.41	88.39	89.16	74.35	68.57	57.17	54.04	56.97	40.84	27.72	37.68	24.38	17.92	21.69	23.26	20.99	25.68	30.36
Forward PE	14.33	16.57	17.53	16.52	17.06	14.81	16.93	14.70	16.26	13.96	13.59	12.15	14.30	12.72	9.96	10.88	11.43	10.04	8.24	8.88
PEG Ratio	0.83	1.09	1.17	1.28	1.27	1.68	1.92	1.86	2.21	58.43	12.71	16.26	7.71	-	15.63	5.63	9.40	2.03	1.98	2.19
PS Ratio	5.95	6.61	6.86	5.62	6.45	5.57	6.28	5.51	5.91	5.04	4.77	4.24	4.95	4.93	4.10	4.72	5.05	4.26	3.46	3.70
PB Ratio	-	-123.54	-154.89	-1791.28	260.61	94.34	57.85	44.69	40.16	26.42	21.76	18.48	21.18	16.57	14.84	18.48	17.59	15.54	14.07	15.84
P/TBV Ratio	-111.82	-123.96	-155.29	-1796.35	261.46	94.54	58.01	44.82	40.32	26.51	21.83	18.55	21.32	16.65	14.90	18.56	17.70	15.62	14.15	15.92
P/FCF Ratio	20.41	22.67	20.79	17.97	24.05	17.59	22.34	17.04	14.69	12.40	10.64	9.59	11.95	11.79	10.83	12.19	12.99	10.89	8.80	10.17
P/OCF Ratio	19.11	21.23	19.62	17.00	22.56	16.68	21.14	16.25	14.17	11.98	10.31	9.31	11.60	11.46	10.51	11.81	12.56	10.51	8.45	9.73
EV/Sales Ratio	6.98	7.52	7.89	6.68	7.51	6.54	7.21	6.32	6.75	5.76	5.54	5.08	5.88	5.79	4.94	5.61	6.04	5.23	4.58	4.93
EV/EBITDA Ratio	14.59	19.82	27.20	20.27	23.40	21.03	18.04	16.73	17.14	14.59	12.81	10.90	13.51	12.63	11.01	12.57	12.73	11.11	10.02	10.88
EV/EBIT Ratio	20.21	30.53	52.02	35.55	42.80	40.33	28.96	28.34	28.73	24.54	20.28	16.38	20.64	18.54	16.16	18.51	18.47	16.39	15.21	17.02
EV/FCF Ratio	23.95	25.83	23.89	21.38	28.02	20.67	25.62	19.56	16.78	14.19	12.36	11.49	14.19	13.85	13.04	14.49	15.53	13.36	11.65	13.53
Debt / Equity Ratio	-19.03	-19.03	-25.69	-496.49	45.23	17.94	9.64	8.51	7.93	5.02	4.59	4.33	4.46	3.42	3.77	4.15	3.89	4.16	5.46	5.90
Debt / EBITDA Ratio	2.91	10.34	17.33	10.15	12.11	109.71	12.03	11.53	15.19	11.27	13.45	9.01	12.69	8.26	10.22	13.64	10.85	10.87	12.55	12.37
Debt / FCF Ratio	3.79	13.81	10.35	14.43	49.92	9.94	13.67	34.80	19.24	13.06	8.26	9.94	15.45	8.77	9.38	15.00	15.48	15.69	10.46	17.50
Net Debt / Equity Ratio	-19.03	-19.03	-23.87	-349.80	45.57	18.52	10.58	8.48	6.99	4.50	3.92	4.06	4.17	3.13	3.61	4.30	4.05	4.34	5.05	5.85
Net Debt / EBITDA Ratio	2.68	9.53	15.90	9.22	11.21	100.64	10.79	9.38	11.48	8.84	10.51	7.71	11.31	7.06	8.48	11.78	9.73	9.48	10.64	11.07
Net Debt / FCF Ratio	3.49	12.73	9.49	13.11	46.22	9.12	12.27	28.31	14.54	10.24	6.45	8.51	13.78	7.49	7.78	12.95	13.89	13.68	8.87	15.66
Asset Turnover	0.12	0.12	0.11	0.11	0.09	0.11	0.10	0.10	0.09	0.10	0.10	0.10	0.09	0.11	0.10	0.10	0.09	0.10	0.10	0.09
Inventory Turnover	3.99	1.00	1.13	0.95	0.91	1.06	1.00	1.02	1.01	1.49	1.81	1.14	1.09	1.24	1.60	1.23	1.20	1.34	1.34	1.22
Quick Ratio	0.41	0.41	0.47	0.48	0.48	0.43	0.44	0.59	0.72	0.63	0.71	0.63	0.66	0.69	0.69	0.61	0.56	0.56	0.75	0.65
Current Ratio	0.67	0.67	0.72	0.74	0.76	0.66	0.65	0.81	0.94	0.87	0.96	0.89	0.96	0.96	0.93	0.84	0.82	0.79	1.01	0.91
Return on Equity (ROE)	2669.12%	2669.12%	10.83%	28.16%	27.11%	-0.33%	17.19%	13.93%	12.85%	5.95%	12.65%	14.70%	1.63%	15.11%	26.70%	6.80%	29.91%	28.35%	22.03%	5.63%
Return on Assets (ROA)	2.30%	2.30%	0.36%	2.12%	2.03%	-0.01%	2.06%	1.84%	1.54%	1.59%	1.50%	2.52%	1.01%	3.22%	2.85%	1.78%	2.93%	3.24%	2.49%	1.97%
Return on Invested Capital (ROIC)	3.23%	3.23%	0.50%	2.99%	2.91%	-0.02%	2.89%	2.57%	2.16%	2.22%	2.09%	3.33%	1.30%	4.21%	3.75%	2.25%	3.69%	4.07%	3.13%	2.42%
Return on Capital Employed (ROCE)	4.86%	4.86%	1.95%	4.96%	3.60%	-1.54%	3.80%	3.94%	2.61%	3.10%	2.17%	4.26%	2.54%	4.99%	4.02%	2.89%	4.12%	4.35%	3.50%	3.64%
Earnings Yield	1.15%	1.03%	0.57%	1.13%	1.12%	1.34%	1.46%	1.75%	1.85%	1.76%	2.45%	3.61%	2.65%	4.10%	5.58%	4.61%	4.30%	4.76%	3.89%	3.29%
FCF Yield	4.90%	4.41%	4.81%	5.56%	4.16%	5.68%	4.48%	5.87%	6.81%	8.06%	9.40%	10.43%	8.37%	8.48%	9.24%	8.20%	7.70%	9.18%	11.37%	9.83%
Dividend Yield	3.35%	0.72%	0.71%	0.89%	0.79%	0.88%	0.79%	0.91%	0.86%	0.96%	1.00%	1.10%	0.94%	0.87%	1.05%	0.92%	0.88%	0.96%	1.21%	1.16%
Payout Ratio	285.59%	160.30%	1565.05%	310.23%	227.45%	-12509.09%	176.23%	200.73%	202.48%	319.46%	147.75%	129.69%	1113.39%	101.33%	63.41%	271.32%	56.26%	57.22%	72.82%	301.57%
Buyback Yield / Dilution	0.20%	0.20%	0.29%	0.37%	0.32%	0.48%	0.32%	0.38%	0.34%	0.65%	0.67%	0.76%	0.63%	0.43%	0.56%	0.49%	0.46%	0.29%	0.44%	0.42%
Total Shareholder Return	3.56%	0.92%	1.00%	1.26%	1.11%	1.35%	1.11%	1.28%	1.20%	1.61%	1.67%	1.86%	1.57%	1.30%	1.61%	1.41%	1.34%	1.25%	1.65%	1.58%

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q